21st week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170143692 | COMPOSITIONS AND METHODS FOR TREATMENT | 2017-05-25 |
20170143693 | COMPOSITIONS AND METHODS FOR TREATMENT | 2017-05-25 |
20170143694 | METALLOENZYME INHIBITOR COMPOUNDS | 2017-05-25 |
20170143695 | COATED PARTICLES | 2017-05-25 |
20170143696 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USES THEREOF | 2017-05-25 |
20170143697 | METHODS OF PROVIDING ANALGESIA | 2017-05-25 |
20170143698 | Compositions and Methods for Delivery of Poorly Soluble Drugs | 2017-05-25 |
20170143699 | EXTENDED RELEASE, ABSUE DETERRENT PHARMACEUTICAL COMPOSITIONS | 2017-05-25 |
20170143700 | SYNTHESIS OF (R)-N-METHYLNALTREXONE | 2017-05-25 |
20170143701 | CARBOHYDRATE METABOLISM-AMELIORATING AGENT | 2017-05-25 |
20170143702 | Treatment of Motor Neuronopathies | 2017-05-25 |
20170143703 | TOXIC RNA INHIBITORS SELF-ASSEMBLED IN SITU | 2017-05-25 |
20170143704 | CANNABINOID RECEPTOR MODULATORS | 2017-05-25 |
20170143705 | PYRAZINE DERIVATIVES AS ENAC BLOCKERS | 2017-05-25 |
20170143706 | SELECTIVE KINASE INHIBITORS | 2017-05-25 |
20170143707 | SYNERGISTIC CLOFAZIMINE/METRONIDAZOLE COMBINATION FOR TREATING CLOSTRIDIUM DIFFICILE | 2017-05-25 |
20170143708 | COMPOUNDS, COMPOSITIONS AND METHODS OF AGELASTATIN ALKALOIDS | 2017-05-25 |
20170143709 | (S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2017-05-25 |
20170143710 | PHARMACEUTICALLY ACCEPTABLE SALTS OF PIRLINDOLE ENANTIOMERS FOR USE IN MEDICINE | 2017-05-25 |
20170143711 | NOVEL USES | 2017-05-25 |
20170143712 | Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate | 2017-05-25 |
20170143713 | MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2017-05-25 |
20170143714 | Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient | 2017-05-25 |
20170143715 | PHARMACEUTICAL COMPOSITIONS | 2017-05-25 |
20170143716 | METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY | 2017-05-25 |
20170143717 | ANTI-TUMOR USE OF ANAGRELIDE AND DERIVATIVES THEREOF | 2017-05-25 |
20170143718 | PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME | 2017-05-25 |
20170143719 | STABLE FORMULATION OF PHENOBARBITAL SODIUM INJECTION | 2017-05-25 |
20170143720 | CALCIUM FOLATE (CAFOLATE) AND THERAPEUTIC METHODS BASED THEREON | 2017-05-25 |
20170143721 | COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL | 2017-05-25 |
20170143722 | SUBSTITUTED PYRROLIDINES AS ROS TYROSINE KINASE INHIBITORS | 2017-05-25 |
20170143723 | PHARMACEUTICAL COMBINATIONS | 2017-05-25 |
20170143724 | THEOBROMINE OR ITS DERIVATIVES FOR THE TREATMENT OR PREVENTION OF RENAL LITHIASIS | 2017-05-25 |
20170143725 | COMBINATION COMPRISING AN ATP ANALOG AND AN ADENOSINE RECEPTOR ANTAGONIST OR A NUCLEOBASE NUCLEOSIDE ANALOG FOR THE TREATMENT OF CANCER | 2017-05-25 |
20170143726 | ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS TO MODULATE T CELL RESPONSES | 2017-05-25 |
20170143727 | USE OF CINNABARINIC ACID AS A MODULATOR OF IMMUNE RESPONSE IN AUTOIMMUNE DISORDERS | 2017-05-25 |
20170143728 | METHOD OF TREATING CONDITIONS WITH KINASE INHIBITORS | 2017-05-25 |
20170143729 | SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR | 2017-05-25 |
20170143730 | Imidazopyridine Compounds and Uses Thereof | 2017-05-25 |
20170143731 | NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS | 2017-05-25 |
20170143732 | SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF | 2017-05-25 |
20170143733 | COMPOUNDS AND METHODS FOR SKIN REPAIR | 2017-05-25 |
20170143734 | PRODRUGS OF METOPIMAZINE | 2017-05-25 |
20170143735 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | 2017-05-25 |
20170143736 | METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE. | 2017-05-25 |
20170143737 | COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER | 2017-05-25 |
20170143738 | SOLID FORMULATION AND METHOD FOR STABILIZING THE SAME | 2017-05-25 |
20170143739 | PHARMACEUTICAL COMPOSITION OR GROUP OF COMPOSITIONS FOR INHIBITING AUTOCRINE HCG PRODUCTION IN ADULT HUMAN CELLS | 2017-05-25 |
20170143740 | ANESTHETIC FORMULATION | 2017-05-25 |
20170143741 | Controlled Release and Taste Masking Oral Pharmaceutical Compositions | 2017-05-25 |
20170143742 | BERBERINE-URSODEOXYCHOLIC ACID CONJUGATE FOR TREATING THE LIVER | 2017-05-25 |
20170143743 | FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE | 2017-05-25 |
20170143744 | STABLE LIQUID FORMULATIONS OF CYCLOPHOSPHAMIDE AND PROCESSES TO PREPARE THE SAME | 2017-05-25 |
20170143745 | INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS | 2017-05-25 |
20170143746 | PHOSPHATE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017-05-25 |
20170143747 | COMPOSITIONS FOR ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN | 2017-05-25 |
20170143748 | ANTI-TUMOR PHARMACEUTICAL APPLICATION OF PENTACYCLIC TRITERPENE SAPONIN COMPOUNDS OF SZECHUAN MELANDIUM ROOT | 2017-05-25 |
20170143749 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2017-05-25 |
20170143750 | Treatment Regimen Tiacumicin Compound | 2017-05-25 |
20170143751 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | 2017-05-25 |
20170143752 | METHOD AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY DISORDERS | 2017-05-25 |
20170143753 | SOPHOROLIPID ESTER CHAIN LENGTH DEPENDENCE ON THE INHIBITION OF HUMAN PATHOGENS | 2017-05-25 |
20170143754 | Dendritic Cell Immune Receptor Activator, Method for Activating Dendritic Cell Immune Receptor, Osteoclast Formation Inhibitor, Method for Inhibiting Osteoclast Formation, Dendritic Cell Differentiation/Proliferation Inhibitor, Method for Inhibiting Dendritic Cell Differentiation/Proliferation, Cytokine Production Inhibitor, Method for Inhibiting Cytokine Production, Therapeutic Method and Screening Method | 2017-05-25 |
20170143755 | CHITOSAN DERIVATIVES FOR INACTIVATION OF ENDOTOXINS AND SURFACE PROTECTION OF NANOPARTICLES | 2017-05-25 |
20170143756 | Antitumor Composition Based on Hyaluronic Acid and Inorganic Nanoparticles, Method of Preparation Thereof and Use Thereof | 2017-05-25 |
20170143757 | MANDELIC ACID CONDENSATION POLYMERS | 2017-05-25 |
20170143758 | INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES | 2017-05-25 |
20170143759 | PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF | 2017-05-25 |
20170143760 | UNIVERSAL CARDIOPLEGIC SOLUTION (VARIANTS) | 2017-05-25 |
20170143761 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION AND/OR INFLAMMATION | 2017-05-25 |
20170143762 | GRAPHENE AND GRAPHENE-RELATED MATERIALS FOR MANIPULATION OF CELL MEMBRANE POTENTIAL | 2017-05-25 |
20170143763 | ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE | 2017-05-25 |
20170143764 | MENSTRUAL BLOOD-DERIVED STEM CELLS FOR THE TREATMENT OF HUMAN PANCREATIC CARCINOMA | 2017-05-25 |
20170143765 | CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF | 2017-05-25 |
20170143766 | STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE | 2017-05-25 |
20170143767 | COMPOSITION COMPRISING CELL AND BIOCOMPATIBLE POLYMER | 2017-05-25 |
20170143768 | OINTMENT FOR THE TREATMENT OF HEMORRHOIDAL DISEASE | 2017-05-25 |
20170143769 | HUMAN UMBILICAL CORD BLOOD-DERIVED MONOCYTES FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | 2017-05-25 |
20170143770 | SOFT TISSUE REPAIR AND REGENERATION USING POSTPARTUM-DERIVED CELLS AND CELL PRODUCTS | 2017-05-25 |
20170143771 | COMPOSITION CONTAINING PSEUDOMONAS AERUGINOSA CULTURE SOLUTION EXTRACT HAVING ANTIBIOTIC AND ANTISEPTIC ACTIVITIES, AND USE THEREOF | 2017-05-25 |
20170143772 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2017-05-25 |
20170143773 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2017-05-25 |
20170143774 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2017-05-25 |
20170143775 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2017-05-25 |
20170143776 | FORMULATION AND TREATMENT FOR ACNE | 2017-05-25 |
20170143777 | COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF | 2017-05-25 |
20170143778 | A METHOD OF FEEDING AN ANIMAL TO IMPROVE GROWTH EFFICIENCY | 2017-05-25 |
20170143779 | AAV Mediated Exendin-4 Gene Transfer to Salivary Glands to Protect Subjects from Diabetes or Obesity | 2017-05-25 |
20170143780 | COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS | 2017-05-25 |
20170143781 | PAIN RELIEF COMPOSITION | 2017-05-25 |
20170143782 | EXTRACTS AND ISOLATED COMPOUNDS FROM CAKILE ARABICA FOR TREATMENT OF ULCER | 2017-05-25 |
20170143783 | SOLID FORMULATION AND METHOD FOR PREVENTING OR REDUCING COLORATION THEREOF | 2017-05-25 |
20170143784 | MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY | 2017-05-25 |
20170143785 | PEPTIDE AS ABSORPTION ENHANCER AND COMPOSITION CONTAINING SAME | 2017-05-25 |
20170143786 | INTRAVAGINAL FORMULATIONS COMPRISING GnRH | 2017-05-25 |
20170143787 | CHEMOKINE RECEPTOR ANTAGONIST AND ITS COMBINATIONAL THERAPY | 2017-05-25 |
20170143788 | COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES, AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS | 2017-05-25 |
20170143789 | AGONISTS OF GUANYLATE CYCLASE AND THEIR USES | 2017-05-25 |
20170143790 | OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA | 2017-05-25 |
20170143791 | OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS | 2017-05-25 |